Clinical Trial

18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
\<75% participation
Summary
This study is being done to learn how 18F-FSPG PET/CT scan results may be related to the response to chemotherapy and radiation in patients with esophageal cancer.
Protocol Amendment History 6 changes
critical Trial terminated 2026-08-14
critical Trial terminated: \<75% participation 2026-08-14
notable Primary completion moved earlier: 2027-12-31 -> 2026-08-06 2026-08-14
minor Completion moved earlier: 2027-12-31 -> 2026-08-06 2026-08-14
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-15
notable Enrollment reduced: 60 -> 9 participants 2026-05-15
Trial Details
NCT Number NCT06549413
Lead Sponsor M.D. Anderson Cancer Center
Conditions Esophageal Carcinoma
Enrollment 9 participants
Start Date 2023-08-23
Primary Completion 2026-08-06 (estimated)
Study Completion 2026-08-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-13